AstraZeneca Licenses Novel Lung Cancer Drug Zegfrovy in $1.5B Global Deal
AstraZeneca announced a exclusive global license agreement with Dizal Pharmaceutical to develop and commercialize Zegfrovy (sunvozertinib), a highly differentiated, oral irreversible EGFR inhibitor designed for targeted lung cancer...
VerGo Pharma Successfully Concludes Unannounced US FDA Inspection with Zero Observations
VerGo Pharma, a leading Contract Research Organization (CRO), announced the successful completion of an unannounced United States Food and Drug Administration (US FDA) inspection at...
Prime Minister Inaugurates Advanced Healthcare Infrastructure Worth ₹4,700+ Crore at PGIMER Chandigarh
Prime Minister Shri Narendra Modi today dedicated major healthcare infrastructure expansions at the Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, marking...
Jasper Therapeutics Merges with Kira Pharmaceuticals, Secures $132M Funding
Jasper Therapeutics (Nasdaq: JSPR) has finalized its all-stock acquisition of Kira Pharmaceuticals, forming a combined entity focused on treatments for immune-related conditions. Alongside the...
Warburg Pincus Acquires Integrace Private Ltd for ₹1,000 Crore
Global private equity firm Warburg Pincus has successfully completed the acquisition of domestic pharmaceuticals company Integrace Private Ltd from existing shareholders True North and Temasek. While official financial details...
Medtronic and Apollo Hospitals Hyderabad Partner to Launch Advanced 11-Bed ICU Hub
Medtronic has joined forces with Apollo Hospitals Hyderabad to establish a new, state-of-the-art 11-bed Advanced Intensive Care Unit (ICU). Located at the prominent Apollo...
